Henry Schein Lowered to Neutral at Ned Davis Research (HSIC)
Henry Schein (NASDAQ:HSIC) was downgraded by investment analysts at Ned Davis Research from a “buy” rating to a “neutral” rating in a note issued to investors on Monday, ARN reports.
Henry Schein (NASDAQ:HSIC) traded down 0.32% on Monday, hitting $103.145. 71,708 shares of the company’s stock traded hands. Henry Schein has a 52-week low of $73.35 and a 52-week high of $107.75. The stock’s 50-day moving average is $104.0 and its 200-day moving average is $97.. The company has a market cap of $8.921 billion and a P/E ratio of 22.43.
Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.23. The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.39 billion. During the same quarter in the prior year, the company posted $1.11 earnings per share. The company’s quarterly revenue was up 8.6% on a year-over-year basis. Analysts expect that Henry Schein will post $4.89 EPS for the current fiscal year.
A number of other firms have also recently commented on HSIC. Analysts at Zacks reiterated a “neutral” rating on shares of Henry Schein (NASDAQ:HSIC) in a research note to investors on Monday, September 16th. They now have a $110.00 price target on the stock. Finally, analysts at Piper Jaffray Cos. raised their price target on shares of Henry Schein (NASDAQ:HSIC) from $92.00 to $103.00 in a research note to investors on Wednesday, August 7th. They now have a “neutral” rating on the stock. One investment analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the stock. Henry Schein presently has a consensus rating of “Hold” and a consensus target price of $93.86.
Henry Schein, Inc is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.